EXTON, Pa. (AP) — EXTON, Pa. (AP) — West Pharmaceutical Services Inc. (WST) on Thursday reported third-quarter earnings of $136 million.
On a per-share basis, the Exton, Pennsylvania-based company said it had net income of $1.85.
The results beat Wall Street expectations. The average estimate of five analysts surveyed by Zacks Investment Research was for earnings of $1.51 per share.
The medical device company posted revenue of $746.9 million in the period, also exceeding Street forecasts. Four analysts surveyed by Zacks expected $710.9 million.
West Pharmaceutical expects full-year earnings in the range of $6.55 to $6.75 per share, with revenue in the range of $2.88 billion to $2.91 billion.
_____
This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on WST at https://www.zacks.com/ap/WST
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.